References
Schaadt O, Boler H (1978) Loss of bone mineral in axial and peripheral skeleton in aging, prednisone treatment and osteoporosis. In: Dequeker J, Johnston, C. C. Jr. (eds) Noninvasive bone measurements: methodological problems. IRL Press, Oxford and Washington, D.C., pp. 207–214
Gennari C, Bernini M, Nardi P, Fusi L, Francini G, Nami R, Montagnani M, Imbimbo B, Avioli LV (1983) Glucocorticoids: radiocalcium and radiophosphate absorption in man. In: Dixon A St J., Russell RGG, Stamp TCB (eds) Osteoporosis: a multi-disciplinary problem. Academic Press and Grune and Stratton, London and New York, pp 75–80
Klein RG, Arnaud SB, Gallagher JC, DeLuca HF, Riggs BL (1977) Intestinal calcium absorption in exogenous hypercortisonism. J Clin Invest 60:253–259
Hahn TJ, Halstead LR, Baran DT (1981) Effects of short-term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab 52:111–115
Reid DM, Kennedy NSJ, Smith MA, Tothill P, Nuki G (1982) Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. Br Med J 285:330–332
Gluck OS, Murphy WA, Hahn TJ, Hahn BH (1981) Bone loss in adults receiving alternate day glucocorticoid therapy: a comparison with daily therapy. Arthritis Rheum 24:892–898
Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH (1979) Altered mineral metabolism in glucocorticoid-induced osteopenia: effect of 25-hydroxyvitamin D administration. J Clin Invest 64:655–665
Fucik RF, Kukreja SC, Hargis GK, Bowser EN, Henderson WJ, Williams GA (1975) Effect of glucocorticoids on function of the parathyroid glands in man. J Clin Endocrinol Metab 40:152–155
Lo Cascio V, Adami S, Avioli LV, Cominacini L, Galvanini G, Gennari C, Imbimbo B, Scuro LA (1982) Suppressive effect of chronic glucocorticoid treatment on circulating calcitonin in man. Calcif Tissue Int 34:309–310
Suzuki Y, Ichikawa Y, Saito E, Homma M (1983) Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 32:151–156
Baxter JD (1978) Mechanisms of glucocorticoid inhibition of growth. Kidney Int 14:330–333
Bressot C, Meunier PJ, Chapuy MC, Lejeune E, Edouard C, Darby AJ (1979) Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metab Bone Dis Rel Res 1:303–311
Canalis E, (1983) Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae. Endocrinology 112:931–939
Wong GL (1979) Basal activities and hormone responsiveness of osteoclast-like and osteoblast-like bone cells are regulated by glucocorticoids. J Biol Chem 254:6337–6340
Schiatti P, Selva D, Barone D, Restelli A, Glässer A (1980) Antiinflammatory activity and other pharmacological properties of 11β, 21-dihydroxy-2′-methyl-5′β H-pregna-1,4-dieno[17,16-d] oxazole-3,20-dione-21-acetate (deflazacort). Drug Res 30:1543–1549
Buniva G, Dubini A, Sassella D (1979) Human bioassay of corticotropin-suppressing, eosinopenic and hyperglycaemic potencies of deflazacort and prednisone. Curr Therap Res 146:69–81
Criscuolo D, Fraioli F, Bonifacio V, Paolucci D, Isidori A (1980) Effects of a new glucocorticoid, deflazacort, on pituitary-adrenal function in man: a comparison with prednisone. J CLin Pharmacol, Ther Toxicology 18:37–41
Martinelli E, Ferrari P, Ripamonti A, Tuan G, Perazzi A, Assandri, A (1979) Metabolism of deflazacort in the rat, dog and man. Am Soc Pharm Exp Ther 7:335–339
Hahn TJ, Halstead LR, Strates B, Imbimbo B, Baran DT (1980) Comparison of subacute effects of oxazacort and prednisone on mineral metabolism in man. Calcif Tissue Int 31:109–115
Rights and permissions
About this article
Cite this article
Peck, W., Gennari, C., Raisz, L. et al. Corticosteroids and bone. Calcif Tissue Int 36, 4–7 (1984). https://doi.org/10.1007/BF02405286
Issue Date:
DOI: https://doi.org/10.1007/BF02405286